Thursday, May 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Nanostructured Active Therapeutics Proposal Deadline Extended

by Global Biodefense Staff
December 31, 2012

The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has extended the proposal receipt deadline for the Nanostructured Active Therapeutic Vehicles (NATV) initiative. 

The NATV program seeks to advance nanostructured therapeutic materials designed for prophylactic or pre-symptomatic chemical and biological medical countermeasures. Two target-centric thrust areas are emphasized for novel advances: 

Thrust 1: Small-molecule antibiotics, such as those used against Gram-negative bacterial pathogens, particularly Burkholderia mallei and Francisella tularensis. A particular challenge in this thrust is demonstration of targeting infected cells and transport of the therapeutic into the bacterium. 

Thrust 2: Large-molecule bioscavenger Butyrylcholinesterase (BuChE) to deliver broad-spectrum protection against all classes of nerve agents. 

The new submission date for proposals is January 25, 2013. Selections are expected to be announced on February 28, 2013. 

Tags: BAABioscavengersBurkholderiaDefense Threat Reduction AgencyF. tularensisNanotech

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC